Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver |
| |
| Authors: | Sandeep Satsangi Nitin Gupta Parul Kodan |
| |
| Affiliation: | 1.Department of Apollo comprehensive Liver Care, Apollo Hospital, Bangalore, Karnataka, India;2.Department of Infectious Diseases, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India;3.Department of Medicine, All India Institute of Medical Sciences, New Delhi, India |
| |
| Abstract: | Corona virus disease (COVID)-19 is caused by the novel severe acute respiratory syndrome coronavirus-2 (commonly referred to as SARS-CoV-2). In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. Though the target organ for the virus is primarily the lungs, with the recent understanding of the pathobiology of this disease and the immune dysregulation associated with it, it is now clear that COVID-19 affects multiple organ systems. Several drugs and therapies have been tried or repurposed to combat the wrath posed by this disease. On October 22, 2020, the USA Food and Drug Administration approved remdesivir for use in adults and pediatric patients (12 years of age and older). Several of the drugs being tried against COVID-19 have hepatotoxicity as their potential side effect. This review aims to provide the latest insights on various drugs being used in the treatment of COVID-19 and their effects on the liver. |
| |
| Keywords: | COVID-19 Drugs Liver Drug-induced liver injury |
|
|
